Spots Global Cancer Trial Database for Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)
Official Title: A Multicenter Study With an Open Label Phase Ib Part Followed by a Randomized, Placebo-controlled, Double-blind, Phase II Part to Evaluate Efficacy, Safety, Tolerability, and PK of M3814 in Combination With Etoposide and Cisplatin in Subjects With Treatment-naïve Small Cell Lung Cancer (SCLC) Extensive Disease (ED)
Study ID: NCT03116971
Conditions
Study Description
Brief Summary: M3814 is an investigational drug under evaluation for treatment of lung cancer. The purpose of the study was to assess the Safety and Efficacy of M3814 in combination with chemotherapy with SCLC ED.
Detailed Description: The study was intended to be a phase I/II trial, but the study never moved forward to Phase II due to recruitment challenges.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research site, Mesa, Arizona, United States
Research site 1, Santa Rosa, California, United States
Research site, Santa Rosa, California, United States
Research site, Whittier, California, United States
Research site, Danbury, Connecticut, United States
Research site, Norwalk, Connecticut, United States
Research site, Columbus, Georgia, United States
Research site, Newnan, Georgia, United States
Research site, Topeka, Kansas, United States
Research site, Ashland, Kentucky, United States
Research site, Billings, Montana, United States
Research site, Pinehurst, North Carolina, United States
Research site, Cincinnati, Ohio, United States
Research site, Portland, Oregon, United States
Research site, Philadelphia, Pennsylvania, United States
Research site, Houston, Texas, United States
Research site, Aalst, , Belgium
Research site, Charleroi, , Belgium
Research site, Edegem, , Belgium
Research site, Gent, , Belgium
Research site, Libramont, , Belgium
Research site, Liège, , Belgium
Research site, Roeselare, , Belgium
Research site, Yvoir, , Belgium
Research site 4, Sofia, , Bulgaria
Research site 2, Sofia, , Bulgaria
Research site 6, Sofia, , Bulgaria
Reasearch site 5, Sofia, , Bulgaria
Research site 3, Sofia, , Bulgaria
Research site 1, Sofia, , Bulgaria
Research site, Calgary, Alberta, Canada
Research site, St. John, New Brunswick, Canada
Research site, London, Ontario, Canada
Research site, Toronto, Ontario, Canada
Research site, Benesov, , Czechia
Research site, Olomouc, , Czechia
Research site, Aalborg, , Denmark
Research site, Herlev, , Denmark
Research site, Odense C, , Denmark
Research site, Freiburg, Baden Wuerttemberg, Germany
Research site, Gauting, Bavaria, Germany
Research site, Nuernberg, Bavaria, Germany
Research site, Hannover, Lower Saxony, Germany
Research site, Chemnitz, Saxony, Germany
Research site, Kiel, Schleswig-Holstein, Germany
Research site, Luebeck, Schleswig-Holstein, Germany
Research site 1, Berlin, , Germany
Research site 2, Berlin, , Germany
Research site 1, Budapest, , Hungary
Research site 2, Budapest, , Hungary
Research site 3, Budapest, , Hungary
Research site, Farkasgyepu, , Hungary
Research site, Szekszard, , Hungary
Research site, Szolnok, , Hungary
Research site, Rozzano, Milano, Italy
Research site, Catania, , Italy
Research site, Genova, , Italy
Research site, Napoli, , Italy
Research site, Ravenna, , Italy
Research site, Reggio Emilia, , Italy
Research site, Roma, , Italy
Research site, Torino, , Italy
Research site, Olsztyn, , Poland
Research site, Poznan, , Poland
Research site, Warszawa, , Poland
Research site, Wodzislaw Slaski, , Poland
Research site, Baia Mare, , Romania
Research site, Cluj-Napoca, , Romania
Research site, Cluj-Napoca, , Romania
Research site, Craiova, , Romania
Research site, Timisoara, , Romania
Research site, Badajoz, , Spain
Research site 1, Madrid, , Spain
Research site 4, Madrid, , Spain
Research site 3, Madrid, , Spain
Research site 2, Madrid, , Spain
Research site, Hull, East Riding Of Yorkshire, United Kingdom
Research site, London, Greater London, United Kingdom
Research site, Sheffield, South Yorkshire, United Kingdom
Research site, Glasgow, Strathclyde, United Kingdom
Contact Details
Name: Medical Responsible
Affiliation: Merck KGaA, Darmstadt, Germany
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
